Fig. 3From: A lipidated bi-epitope vaccine comprising of MHC-I and MHC-II binder peptides elicits protective CD4 T cell and CD8 T cell immunity against Mycobacterium tuberculosisImmunization with L4.8 evokes CTL activity. Mice were immunized, and cultures were set as mentioned in the legends to Fig. 1. The expression of KLRG1 was monitored on CD4 T cells and CD8 T cells by flow cytometry and represented as: a, b histogram plots; c, d bar diagrams. e, f The lytic ability of CTL was evaluated by in vivo killer T cells assay. The data expressed as target lysis are calculated from the ratio of epitope-pulsed CFSEhi and un-pulsed CFSElo to targets. The results are depicted as mean ± SEM (n = 3 mice/group). *p < 0.05, ****p ≤ 0.0001Back to article page